These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9619686)

  • 1. The effect of clinical outcome on platelet G proteins of major depressed patients.
    Karege F; Bovier P; Stepanian R; Malafosse A
    Eur Neuropsychopharmacol; 1998 May; 8(2):89-94. PubMed ID: 9619686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density of guanine nucleotide-binding proteins in platelets of patients with major depression: increased abundance of the G alpha i2 subunit and down-regulation by antidepressant drug treatment.
    García-Sevilla JA; Walzer C; Busquets X; Escribá PV; Balant L; Guimón J
    Biol Psychiatry; 1997 Oct; 42(8):704-12. PubMed ID: 9325564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome.
    Karege F; Widmer J; Bovier P; Gaillard JM
    Neuropsychopharmacology; 1994 May; 10(3):207-14. PubMed ID: 7916918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L; Septien L; Azoulay P
    CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of paroxetine and imipramine in depressed outpatients.
    Melton ST; Kirkwood CK; Farrar TW; Brink DD; Carroll NV
    Psychopharmacol Bull; 1997; 33(1):93-100. PubMed ID: 9133757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
    Samuelian JC; Hackett D
    J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada.
    Lapierre Y; Bentkover J; Schainbaum S; Manners S
    Can J Psychiatry; 1995 Sep; 40(7):370-7. PubMed ID: 8548716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WHO Depression Scale. Relationship to the Newcastle Scales.
    Bech P; Gram LF; Reisby N; Rafaelsen OJ
    Acta Psychiatr Scand; 1980 Aug; 62(2):140-53. PubMed ID: 7468286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet imidazoline receptors and regulatory G proteins in patients with major depression.
    García-Sevilla JA; Escribá PV; Busquets X; Walzer C; Guimón J
    Neuroreport; 1996 Dec; 8(1):169-72. PubMed ID: 9051774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
    Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S
    Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economics of treatment of depression.
    Owens DW
    Br J Psychiatry; 1995 Jul; 167(1):112. PubMed ID: 7551591
    [No Abstract]   [Full Text] [Related]  

  • 17. High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.
    Marazziti D; Perugi G; Deltito J; Lenzi A; Maremmani I; Placidi GF; Cassano GB
    Psychiatry Res; 1988 Feb; 23(2):229-37. PubMed ID: 2834766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant response follows an exponential decay curve: replication and extension.
    Boyer W
    J Clin Psychopharmacol; 1997 Oct; 17(5):426-7. PubMed ID: 9315997
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost analysis of paroxetine versus imipramine in major depression.
    Bentkover JD; Feighner JP
    Pharmacoeconomics; 1995 Sep; 8(3):223-32. PubMed ID: 10155618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine.
    Maes M; Van Gastel A; Delmeire L; Meltzer HY
    Biol Psychiatry; 1999 Feb; 45(3):278-84. PubMed ID: 10023502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.